These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8528938)

  • 1. Interferon-alpha inhibits erythropoietin-induced proliferation, but not differentiation, and restricts erythroleukemia development.
    Lai CM; Swaminathan N; Beilharz MW; Papadimitriou J; Klinken SP
    J Interferon Cytokine Res; 1995 Aug; 15(8):669-75. PubMed ID: 8528938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid fatal erythroleukemia caused by J2E cells can be treated ex vivo with erythropoietin.
    Farr TJ; Lai CM; Beilharz MW; Papadimitriou J; Riches K; Rossi E; Garcia-Webb P; Klinken SP
    Leukemia; 1995 May; 9(5):900-7. PubMed ID: 7769854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of a fatal transplantable erythroleukemia by procedures that lower endogenous erythropoietin.
    Hossain A; Kim JK; Hankins WD
    J Cell Biochem; 1986; 30(4):311-8. PubMed ID: 3458710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo.
    Cull V; Tilbrook PA; Adenan AS; Chappell D; Ingley E; Sarna MK; Palmer TN; Watowich SS; Klinken SP
    Oncogene; 2000 Feb; 19(7):953-60. PubMed ID: 10702804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirally-produced erythropoietin effectively induces differentiation and proliferation of J2E erythroid cells.
    Busfield SJ; Riches KJ; Sainsbury AJ; Rossi E; Garcia-Webb P; Klinken SP
    Growth Factors; 1993; 9(2):87-97. PubMed ID: 8217220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiloride suppresses erythropoietin-induced proliferation and MAP kinase, but potentiates differentiation of J2E cells.
    Callus B; Tilbrook PA; Busfield SJ; Cull VS; Bittorf T; Klinken SP
    Exp Cell Res; 1995 Jul; 219(1):39-46. PubMed ID: 7543055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
    Ruscetti SK
    J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia.
    Jacobs-Helber SM; Roh KH; Bailey D; Dessypris EN; Ryan JJ; Chen J; Wickrema A; Barber DL; Dent P; Sawyer ST
    Blood; 2003 Jan; 101(2):524-31. PubMed ID: 12393629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Leukemia Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation.
    Winteringham LN; Kobelke S; Williams JH; Ingley E; Klinken SP
    Oncogene; 2004 Jun; 23(29):5105-9. PubMed ID: 15122318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction.
    Busfield SJ; Klinken SP
    Blood; 1992 Jul; 80(2):412-9. PubMed ID: 1627799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
    Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
    Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3.
    Shiozaki M; Itoh K; Mori KJ
    Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
    Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
    Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells.
    Tilbrook PA; Ingley E; Williams JH; Hibbs ML; Klinken SP
    EMBO J; 1997 Apr; 16(7):1610-9. PubMed ID: 9130706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
    Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
    Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.